WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled:
“Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.
Dr. Steve Brozak, President of WBB Securities, has authored a new opinion piece in Forbes
Read More about President Donald Trump – Will He Become the Drug Price Equalizer?
WBB Securities is pleased to share a featured interview with our Managing Director, Dr. Steve Brozak, published in The Wall Street Transcript on April 29, 2025.
Read More about Onshoring Drug Manufacturing Is Critical But Not EasyPharmaceutical tariffs are looming again, and the stakes are higher than ever.
Read More about Pharma Dodges The Tariff Bullet—But For How Long?The Trump administration just levied tariffs on China, Mexico, and Canada with a message: it’s not about trade, it’s about fentanyl.
Read More about As Tariffs Begin; What Will They Do To Drug Prices And Availability?The Need for Novel Responses to Disease Threats in a Fast-Changing World.
Read More about Dr. Steve Brozak, President of WBB Securities, will moderate a panel at the Biotech Showcase Conference on Wednesday, January 15, 2025, titled “The Need for Novel Responses to Disease Threats in a Fast-Changing World.”